Literature DB >> 2605107

Semen cryopreservation in men undergoing cancer chemotherapy--a UK survey.

D W Milligan1, R Hughes, K S Lindsay.   

Abstract

A questionnaire was sent to all centres in the UK involved in cryopreservation of semen from men with malignant disease. Details were requested of samples stored from 1977 to 1987 and of successful use of this sperm in subsequently achieving pregnancy. Twenty-two centres are involved and have stored specimens from 2,219 men. There has been a three-fold increase in referrals in the past five years. Three regions in England have no service. Twenty-seven pregnancies (21 live births) have been achieved in 22 couples. Laboratories are poorly funded, making adequate record keeping and audit of the service difficult.

Entities:  

Mesh:

Year:  1989        PMID: 2605107      PMCID: PMC2247267          DOI: 10.1038/bjc.1989.399

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  Alkylating agents and human spermatogenesis.

Authors:  D G Miller
Journal:  JAMA       Date:  1971-09-20       Impact factor: 56.272

2.  Cancer, chemotherapy, and fertility.

Authors:  J Waxman
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-13

3.  Semen cryopreservation for patients surviving malignant disease: implications of proposed legislation.

Authors:  P Selby; M Brada; A Horwich; E Wiltshaw; T J McElwain; K S Lindsay
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

4.  Cryopreservation of semen in men with testicular tumour or Hodgkin's disease: results of artificial insemination of their partners.

Authors:  G E Scammell; N White; J Stedronska; W F Hendry; D K Edmonds; S L Jeffcoate
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

5.  Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation.

Authors:  W F Hendry; J Stedronska; C R Jones; C A Blackmore; A Barrett; M J Peckham
Journal:  Br J Urol       Date:  1983-12

6.  Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.

Authors:  M F da Cunha; M L Meistrich; L M Fuller; J H Cundiff; F B Hagemeister; W S Velasquez; P McLaughlin; S A Riggs; F F Cabanillas; P G Salvador
Journal:  J Clin Oncol       Date:  1984-06       Impact factor: 44.544

7.  Testicular damage due to cytotoxic drugs and recovery after cessation of therapy.

Authors:  H P Roeser; A E Stocks; A J Smith
Journal:  Aust N Z J Med       Date:  1978-06

8.  Feasibility of semen cryopreservation in patients with malignant disease.

Authors:  W G Sanger; J O Armitage; M A Schmidt
Journal:  JAMA       Date:  1980 Aug 22-29       Impact factor: 56.272

  8 in total
  3 in total

1.  Characteristics of cryopreserved semen from men with lymphoma.

Authors:  J Hallak; A M Mahran; A Agarwal
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

2.  The effects of cryopreservation on semen from men with sarcoma or carcinoma.

Authors:  J Hallak; A Mahran; J Chae; A Agarwal
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

3.  Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease.

Authors:  F H Blackhall; A D Atkinson; M B Maaya; W D J Ryder; G Horne; D R Brison; B A Lieberman; J A Radford
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.